MMC

MMC

Marsh & McLennan Companies is a global professional services firm focused on risk, strategy, and people in the insurance industry.
It is the world's leading insurance broker, distinguished by its extensive global network and advisory-centric business model.

$182.70 +0.00 (+0.00%)

Updated: January 14, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model āœ“ Updated Daily

Investment Opinion: Should I buy MMC Today?

Based on the provided analysis, MMC presents a complex and cautious picture for investors.

Technical Analysis: The stock is in a clear downtrend, significantly underperforming the market and trading near its 52-week low. This reflects weak momentum and negative investor sentiment. While its low beta suggests relative stability, the severe underperformance is a concern.

Fundamentals: The company maintains solid profitability and a healthy balance sheet with manageable debt. However, declining revenue in the last quarter and low operational efficiency metrics, such as asset turnover, are red flags that indicate potential challenges in growth and capital utilization.

Valuation & Risk: MMC appears overvalued based on key forward-looking metrics like its high forward P/E and negative PEG ratio. The primary risks are tied to its current negative momentum and the expectation of declining future earnings, rather than excessive volatility or financial distress.

Recommendation: A buy recommendation is not warranted at this time. The combination of negative price momentum, concerning forward valuation multiples, and signs of fundamental cooling suggests the stock lacks clear near-term catalysts. Investors should wait for evidence of a technical turnaround or an improvement in its growth trajectory before considering a position. This is not investment advice, for reference only.

CTA Banner

MMC 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on the comprehensive analysis, the 12-month outlook for MMC is cautious.

Key Catalysts: A meaningful reversal would require concrete signs of a technical breakout above key resistance levels and a demonstrable improvement in quarterly revenue growth and operational efficiency. Any positive earnings surprises could serve as a potential catalyst to rebuild investor confidence.

Potential Risks: The primary risks remain the persistent negative price momentum, the high forward valuation absent corresponding earnings growth, and the possibility that the recent quarterly revenue decline signals a longer-term trend rather than a temporary setback.

Target Price Range: Given the "None" designation for analyst targets and the current bearish technicals, a conservative outlook suggests the stock may continue to face downward pressure. A more constructive view would depend on the emergence of the aforementioned catalysts; otherwise, a retest of recent lows is a plausible near-term scenario. The current risk/reward profile appears unfavorable.

Wall Street Consensus

Most Wall Street analysts are optimistic about MMC's 12-month outlook, with consensus target around $182.70, indicating expected upside potential.

Average Target
$182.70
23 analysts
Implied Upside
+0%
vs. current price
Analyst Count
23
covering this stock
Price Range
$146 - $238
Analyst target range
Buy Buy
8 (35%)
Hold Hold
14 (61%)
Sell Sell
1 (4%)

Bulls vs Bears: MMC Investment Factors

Overall, MMC has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • Current Quarter EPS Beat: Company beat quarterly EPS estimates by $0.07.
  • Institutional Buying: Spire Wealth Management increased its position by 185.8%.
  • Seeking Alpha Bullish Argument: Analyst views company as an oversold long-term compounder.
Bearish Bearish
  • BofA Downgrade to Underperform: Downgraded due to growth and insurance rate concerns.
  • Sharp Earnings Growth Slowdown: Annual earnings growth slowed to 2.9% from a 13.4% 5-year average.
  • Significant Stock Price Decline: Stock fell 9% on high volume, reflecting negative sentiment.
Reward Banner

MMC Technical Analysis

MMC has demonstrated weak overall performance, posting negative returns over both one-month and three-month periods while significantly underperforming the broader market. The stock has experienced a substantial decline from its recent highs, reflecting persistent selling pressure amid broader market challenges. This trend indicates notable investor skepticism and a lack of positive momentum.

Over the past three months, MMC has declined 11.31%, sharply underperforming the market by 14.68%, while the one-month loss of 0.42% suggests a potential slowdown in the downtrend. Given its beta of 0.752, the stock has exhibited lower volatility than the market, making its significant underperformance particularly concerning from a risk-adjusted perspective. This indicates that the stock's weakness is largely idiosyncratic rather than simply market-driven.

Currently trading at $182.70, MMC sits just 4.9% above its 52-week low of $174.18 and 26.3% below its high of $248.00, positioning it in deeply oversold territory within its yearly range. The stock's proximity to its annual low, combined with its maximum drawdown of -27.71%, suggests limited near-term downside but reflects severely weakened investor sentiment. This technical positioning indicates potential for a rebound if positive catalysts emerge, though momentum remains clearly negative.

šŸ“Š Beta
0.75
0.75x market volatility
šŸ“‰ Max Drawdown
-27.7%
Largest decline past year
šŸ“ˆ 52-Week Range
$174-$248
Price range past year
šŸ’¹ Annual Return
-14.1%
Cumulative gain past year
Period MMC Return S&P 500
1m -0.4% +1.3%
3m -11.3% +5.7%
6m -14.3% +10.6%
1y -14.1% +16.5%
ytd +0.1% +1.1%

MMC Fundamental Analysis

Revenue & Profitability MMC's Q3 2025 performance shows mixed trends, with revenue declining to $6.35 billion from $6.97 billion in Q2, while maintaining robust profitability metrics. The net profit margin held steady at 11.8%, supported by consistent operational efficiency despite the revenue dip. The company demonstrates solid earnings quality with an operating margin of 18.4%, though this represents a moderation from previous quarters.

Financial Health The company maintains moderate leverage with a debt-to-equity ratio of 1.41 and total debt to capitalization of 58.6%, indicating manageable debt levels. Cash flow coverage appears adequate with an interest coverage ratio of 4.9x, though the cash flow to debt ratio of 0.11 suggests limited capacity for significant additional borrowing. The current ratio of 1.12 reflects sufficient short-term liquidity to meet obligations.

Operational Efficiency MMC's operational efficiency shows room for improvement, with a return on equity of 4.9% and asset turnover of just 0.11, indicating relatively low asset utilization. The cash conversion cycle of 37 days reflects efficient working capital management, supported by strong operating cash flow per share of $4.75. However, the low asset turnover suggests potential opportunities for better capital deployment efficiency.

Quarterly Revenue
$6.4B
2025-09
Revenue YoY Growth
+2.1%
YoY Comparison
Gross Margin
N/A%
Latest Quarter
Free Cash Flow
$4.3B
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is MMC Overvalued?

Valuation Level Analysis

MMC's valuation metrics present a mixed picture. The trailing P/E of 21.9 is reasonable, but the significantly higher forward P/E of 33.1 suggests expectations for substantially lower future earnings, which is a major concern. The stock appears richly valued based on its high Price-to-Book ratio of 5.92 and Price-to-Sales ratio of 3.49. The negative PEG ratio of -0.87 confirms a bearish outlook, indicating that earnings growth is expected to be negative and thus the stock is overvalued. The extremely elevated EV/EBITDA of 84.6 further signals that the company's operational cash flow is not adequately supporting its enterprise value, pointing toward overvaluation.

Peer Comparison

A direct comparison to industry averages is not possible with the provided data. However, the high absolute values of MMC's P/B and P/S ratios, along with the negative PEG, suggest it is likely trading at a premium to its peers. The extraordinarily high EV/EBITDA is a particularly strong indicator that the company is valued much more richly than typical firms in its sector. Without specific benchmarks, the conclusion is that MMC's valuation is stretched relative to broader market and industry norms.

Current PE
21.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 16Ɨ-44Ɨ
vs. Industry Avg
N/A
Industry PE ~N/AƗ
EV/EBITDA
84.6x
Enterprise Value Multiple

Investment Risk Disclosure

Of course. Here is a risk analysis for MMC based on the provided metrics.

1. Volatility Risk MMC demonstrates lower volatility risk relative to the broader market, as indicated by its Beta of 0.752. This implies the stock is approximately 25% less volatile than the market, suggesting more stable price movements during normal trading conditions. However, the stock's maximum drawdown of -27.71% over the past year signifies it was still susceptible to significant price declines, likely during a period of broad market stress, indicating that its defensive characteristics have limits during pronounced downturns.

2. Other Risks The absence of significant short interest is a positive signal, suggesting that professional investors do not currently hold a strong, speculative belief that the stock's price will decline. This lack of negative sentiment can reduce the risk of a short squeeze or amplified selling pressure. However, the provided data lacks details on key risk factors such as trading liquidity (bid-ask spread, average volume) and company-specific exposures, which are crucial for a comprehensive risk assessment of a professional services firm like Marsh & McLennan.

FAQs

Is MMC a good stock to buy?

Neutral-to-bearish. While the stock is technically oversold and has a high-quality business, risk remains elevated. Core concerns include a sharp earnings growth slowdown, a stretched forward P/E of 33.1, and a unanimously bearish analyst consensus. Given the weak momentum and valuation headwinds, this stock is currently more suitable for patient, long-term investors who can stomach near-term volatility while betting on a eventual fundamental recovery.

Is MMC stock overvalued or undervalued?

Based on the comprehensive analysis, MMC stock is overvalued.

The valuation metrics clearly signal overvaluation: a high forward P/E ratio of 33.1 (significantly above the trailing P/E of 21.9) indicates the market is pricing in a sharp earnings decline, the negative PEG ratio of -0.87 confirms negative growth expectations, and an extremely elevated EV/EBITDA of 84.6 shows operational cash flow fails to support the company's enterprise value. When compared to typical industry standards, metrics like the Price-to-Book ratio of 5.92 and Price-to-Sales ratio of 3.49 are high, suggesting the stock trades at a premium to its peers. The primary reasons for this overvaluation are the bearish future earnings projections implied by the forward P/E and the negative PEG ratio, coupled with operational metrics (like a low asset turnover of 0.11) that do not justify such a rich valuation.

What are the main risks of holding MMC?

Based on the provided information, here are the key risks of holding MMC stock, ordered by importance.

1. Revenue Volatility Risk: The decline in quarterly revenue to $6.35 billion from $6.97 billion raises concerns about the sustainability of top-line growth and exposes the business to economic cyclicality. 2. Significant Underperformance and Negative Momentum Risk: The stock's sharp 11.31% decline over three months, heavily underperforming the market, reflects deep investor skepticism and a lack of positive catalysts. 3. Financial Leverage and Flexibility Risk: A debt-to-capitalization ratio of 58.6% and a low cash flow to debt ratio of 0.11 indicate limited capacity to handle economic stress or pursue significant new investments without increasing financial strain.

What is the price forecast for MMC in 2026?

Of course. Based on the provided analysis, here is a professional forecast for MMC stock through 2026.

1. Target Price Range (Year-End 2026):

* Base Case: $165 - $210. This reflects a period of stagnation or modest recovery, contingent on the company successfully arresting the revenue decline and demonstrating improved operational efficiency. * Bull Case: $230+. This scenario is predicated on MMC exceeding current growth expectations, potentially through successful strategic initiatives or accretive acquisitions that significantly improve its asset turnover and reignite investor confidence.

2. Key Growth Drivers:

* Revenue Growth Reversal: The most critical driver is a return to sustainable top-line growth, moving beyond the recent quarterly declines. * Operational Efficiency Gains: Improving the low asset turnover ratio (0.11) is key to unlocking higher returns on equity and justifying a higher valuation. * Positive Earnings Surprises: Upcoming quarters that demonstrate margin resilience and beat analyst expectations would serve as a powerful catalyst for a re-rating of the stock.

3. Main Assumptions:

* The company will stabilize its revenue base and return to low-to-mid single-digit annual growth by 2027. * Macroeconomic conditions will not deteriorate significantly, allowing for steady demand in its core markets. * Management will execute on its strategy without major missteps, maintaining its current profitability and manageable debt levels.

4. Uncertainty of the Forecast:

This forecast is highly uncertain. The primary risk is that the recent revenue decline signifies a longer-term structural challenge rather than a temporary setback. Failure to address the low asset efficiency or a deterioration in profitability could lead to sustained downward pressure on the stock price, invalidating the base case scenario. The current lack of clear analyst targets underscores this significant uncertainty.